Development of dual-drug-loaded stealth nanocarriers for targeted and synergistic anti-lung cancer efficacy

Combination chemotherapy is widely exploited for suppressing drug resistance and achieving synergistic anticancer efficacy in the clinic. In this paper, the nanostructured targeting methotrexate (MTX) plus pemetrexed (PMX) chitosan nanoparticles (CNPs) were developed by modifying methoxy polye (thyl...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Drug Deliv
Autores principales: Chen, Juan, Yang, Xiaobing, Huang, Liuqing, Lai, Huixian, Gan, Chuanhai, Luo, Xuetao
Formato: Artigo
Lenguaje:Inglês
Publicado: Taylor & Francis 2018
Materias:
Research Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC6263111/
https://ncbi.nlm.nih.gov/pubmed/30472899
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/10717544.2018.1477856
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares